Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Biogen, Schering-Plough regulatory update

The FDA's Oncologic Drugs Advisory Committee recommended approval of Intron A (interferon alfa-2b)

Read the full 130 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE